EUVIMEDTutustu EUVIMEDiin
Crossref

Medicinal Plants in the Management of Urolithiasis: A Comparative Review of Bryophyllum pinnatum, Phyllanthus niruri, and Aerva lanata

African Journal of Biomedical Research · 2024 · 27 (6)

DOI: 10.69980/p ↗

At a glance

Journal article in African Journal of Biomedical Research, 2024.

TiivistelmäBibliografiset tiedotCiteRelated studies

Abstract (original language)

Background

Urolithiasis is a prevalent and recurrent urological disorder characterized by the formation of crystalline calculi within the urinary tract, with calcium oxalate accounting for nearly 70–80% of all urinary stones. Despite considerable advances in minimally invasive surgery and pharmacological management, recurrence remains common because current interventions primarily remove existing calculi rather than modifying the biological processes responsible for lithogenesis. Consequently, increasing attention has been directed toward medicinal plants possessing multitarget pharmacological activities capable of interfering with crystal formation, oxidative stress, inflammation, and renal tubular injury.

Objective

This review critically evaluates the antiurolithiatic potential of Bryophyllum pinnatum, Phyllanthus niruri, and Aerva lanata by integrating current evidence on their phytochemical composition, pharmacological activities, experimental findings, and mechanisms relevant to calcium oxalate stone formation.

Methods

A narrative literature review was conducted using peer-reviewed publications indexed in PubMed, Scopus, Web of Science, and related biomedical databases. Experimental, preclinical, clinical, and review articles addressing phytochemistry, pharmacology, and antiurolithiatic mechanisms of the selected medicinal plants were critically synthesized with emphasis on mechanistic evidence and translational relevance.

Results

The available literature demonstrates that the selected medicinal plants exhibit complementary antiurolithiatic activities through inhibition of calcium oxalate crystal nucleation, growth, aggregation, and adhesion, together with antioxidant, anti-inflammatory, diuretic, and nephroprotective effects. Among the three species, Phyllanthus niruri possesses the strongest experimental support and limited but encouraging clinical evidence, particularly as an adjunct following extracorporeal shock wave lithotripsy. In contrast, Bryophyllum pinnatum and Aerva lanata remain supported predominantly by experimental investigations demonstrating favorable effects on oxidative stress, urinary biochemical parameters, and crystal deposition. However, heterogeneity in botanical authentication, extraction procedures, phytochemical standardization, dosage regimens, and study designs continues to limit direct comparison and clinical translation.

Conclusion

Bryophyllum pinnatum, Phyllanthus niruri, and Aerva lanata represent promising phytotherapeutic choice for the complementary management of recurrent urolithiasis. Future investigations should prioritize phytochemical standardization, molecular validation of pharmacological mechanisms, pharmacokinetic characterization, and adequately powered randomized clinical trials to facilitate the development of evidence-based phytopharmaceuticals.

Cite

APA

(2024). Medicinal Plants in the Management of Urolithiasis: A Comparative Review of Bryophyllum pinnatum, Phyllanthus niruri, and Aerva lanata. African Journal of Biomedical Research, 27(6). https://doi.org/10.69980/p

Vancouver

Medicinal Plants in the Management of Urolithiasis: A Comparative Review of Bryophyllum pinnatum, Phyllanthus niruri, and Aerva lanata. African Journal of Biomedical Research. 2024;27(6). doi:10.69980/p

BibTeX
@article{euvimed2024,
  title = {Medicinal Plants in the Management of Urolithiasis: A Comparative Review of Bryophyllum pinnatum, Phyllanthus niruri, and Aerva lanata},
  journal = {African Journal of Biomedical Research},
  year = {2024},
  volume = {27},
  number = {6},
  doi = {10.69980/p}
}
Start for free →